University radiology department could face investigation after audit

An internal audit published in late 2010 showed that University of Missouri (UM) Health Care was providing unrequested radiology services, according to the Columbia Tribune.

A follow-up audit from September 2011 indicated the problems have been addressed, but the Columbia Tribune reported that sources in the radiology department have been instructed by the UM System General Counsel’s office not to delete or destroy emails and documents in anticipation of an investigation.

There has been no official comment from the UM System, the U.S. Department of Justice or the Missouri Department of Health and Human Services regarding an investigation.

The Office of Corporate Compliance investigated the department in December 2010 based on a tip that services were being provided without physicians ordering them, according to the Tribune. An audit of Medicare cases revealed that 62.5 percent of a random sample did not have proper physician orders.

“The fact that physician signatures didn’t accompany orders didn’t necessarily mean services were unnecessary,” UM System Attorney Paul McGuffey told the paper.

A corrective action plan was negated by improvements seen at the follow-up audit which were largely because of a computerized order entry system, according to the Tribune.
Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Around the web

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.